C15ORF40 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 5.094000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
8.712200E-01
Normal-vs-Stage2
4.340600E-01
Normal-vs-Stage3
2.524800E-01
Normal-vs-Stage4
5.129400E-01
Stage1-vs-Stage2
1.431590E-01
Stage1-vs-Stage3
1.651550E-01
Stage1-vs-Stage4
3.916800E-01
Stage2-vs-Stage3
2.921400E-01
Stage2-vs-Stage4
9.386800E-01
Stage3-vs-Stage4
2.967600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
4.455400E-01
Normal-vs-AfricanAmerican
6.951400E-01
Normal-vs-Asian
8.678200E-01
Caucasian-vs-AfricanAmerican
7.026200E-01
Caucasian-vs-Asian
2.259000E-01
AfricanAmerican-vs-Asian
5.186600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
3.018600E-01
Normal-vs-Female
7.234200E-01
Male-vs-Female
7.730000E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
7.471800E-01
Normal-vs-Age(41-60Yrs)
8.384600E-01
Normal-vs-Age(61-80Yrs)
3.265800E-01
Normal-vs-Age(81-100Yrs)
7.241600E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
3.536600E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
4.533800E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
5.670200E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
6.980100E-03
Age(41-60Yrs)-vs-Age(81-100Yrs)
3.747000E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
1.399620E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
4.363600E-01
Normal-vs-Daily Drinker
2.730200E-01
Normal-vs-Weekly Drinker
3.737200E-01
Normal-vs-Occasional Drinker
9.900200E-01
Normal-vs-Social Drinker
4.259600E-01
Non Drinker-vs-Daily Drinker
8.680400E-01
Non Drinker-vs-Weekly Drinker
6.112800E-01
Non Drinker-vs-Occasional Drinker
1.930610E-01
Non Drinker-vs-Social Drinker
9.826400E-01
Daily Drinker-vs-Weekly Drinker
6.652200E-01
Daily Drinker-vs-Occasional Drinker
1.843750E-01
Daily Drinker-vs-Social Drinker
8.524200E-01
Weekly Drinker-vs-Occasional Drinker
1.809970E-01
Weekly Drinker-vs-Social Drinker
6.304800E-01
Occasional Drinker-vs-Social Drinker
2.662000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
9.368200E-01
Normal-vs-Grade 2
9.408600E-01
Normal-vs-Grade 3
9.184400E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
6.942000E-01
Grade 1-vs-Grade 3
5.115800E-01
Grade 1-vs-Grade 4
9.368200E-01
Grade 2-vs-Grade 3
6.310000E-01
Grade 2-vs-Grade 4
9.408600E-01
Grade 3-vs-Grade 4
9.184400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
1.937760E-01
Normal-vs-NonDiabetic
6.654000E-01
Diabetic-vs-NonDiabetic
3.783600E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
8.160200E-01
Normal-vs-NoPancreatitis
5.730600E-01
Pancreatitis-vs-NoPancreatitis
5.972400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
5.901800E-01
Normal-vs-N1
4.446000E-01
N0-vs-N1
7.444000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
8.425200E-01
Normal-vs-TP53-NonMutant
7.504800E-01
TP53-Mutant-vs-TP53-NonMutant
6.391600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
